PKD1, the major gene mutated in autosomal dominant polycystic kidney disease, was identified in 1994, and fully sequenced in 1995. The protein which it encodes, polycystin-1, is the first member of a new family of proteins, whose functions presently remain unclear. This review seeks to highlight the difficulties researchers studying polycystin-1 have faced and to summarize the current areas of consensus and controversy between different groups, particularly with regard to the expression pattern, subcellular location and biochemical characterization of polycystin-1. Where relevant, more recent data regarding polycystin-2, the protein encoded by PKD2, will also be discussed.

Keywords:
Polycystin, PKD1, ADPKD, Immunohistochemistry, Western analysis
1.
European Polycystic Kidney Disease Consortium: The polycystic kidney disease-1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994;77:881–894.
2.
Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease-1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151–160.
3.
Ward CJ, Turley H, Ong ACM, Comley M, Biddolph S, Chetty R, Ratcliffe PJ, Gatter K, Harris PC: Polycystin, the polycystic kidney disease-1 protein, is expressed by epithelial cells in fetal, adult and polycystic kidney. Proc Natl Acad Sci USA 1996;93:1524–1528.
4.
Griffin MD, Torres VE, Grande JP, Kumar R: Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Physicians 1996;108:185–197.
5.
Palsson R, Sharma CP, Kim K, McLaughlin M, Brown D, Arnaout MA: Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene-1. Mol Med 1996;2:702–711.
6.
Peters DJM, Spruit L, Klingel R, Prins F, Baelde HJJ, Giordano PC, Bernini LF, de Heer E, Breuning MH, Bruijn JA: Adult, fetal and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest 1996;75:221–230.
7.
Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glucksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, Zhou J: Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996;98:2674–2682.
8.
Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, Van Raay T, Bradley J, Qian F, Onuchic LF, Watnick TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger KW: Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 1997;94:6397–6402.
9.
Van Adelsberg J, Chamberlain S, D’Agati V: Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol 1997;272:F602-F609.
10.
Weston BS, Jeffery S, Jeffery I, Sharaf SFA, Carter N, Saggar-Malik A, Price RG: Polycystin expression during embryonic development of human kidney in adult tissues and ADPKD tissue. Histochem J 1997;29:847–856.
11.
Geng L, Segal Y, Pavlova A, Barros EJG, Lohning C, Lu W, Nigam SK, Frischauf AM, Reeders S, Zhou J: Distribution and developmentally regulated expression of murine polycystin. Am J Physiol 1997;272:F451–F459.
12.
Ong ACM, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC: Coordinate expression of the ADPKD proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 1999;154:1721–1729.
13.
Ong ACM, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJT, Migone N, Ward CJ: Polycystin-1 expression in PKD1, early onset PKD1 and TSC2/PKD1 cystic tissue: Implications for understanding cystogenesis. Kidney Int 1999;56:1324–1333.
14.
Griffin MD, Torres VE, Grande JP, Kumar R: Vascular expression of polycystin. J Am Soc Nephrol 1997;8:616–626.
15.
Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhusien B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJM, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339–1342.
16.
Wu G, D’Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou J Jr, Kucherlapati R, Edelmann W, Somlo S: Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998;93:177–188.
17.
Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J: Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997;17:179–181.
18.
Lu W, Fan X, Basora N, Babakhanlou H, Law T, Rifai N, Harris PC, Perez-Atayde AR, Rennke HG, Zhou J: Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 1999;21:160–161.
19.
Ong ACM, Harris PC: Molecular basis of renal cyst formation – One hit or two? Lancet 1997;349:1039–1040.
20.
Koptides M, Hadjimichael C, Koupepidou P, Pierides A, Deltas CC: Germinal and somatic mutations in the PKD2 gene in renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet 1999;8:509–513.
21.
Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG: PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997;16:179–183.
22.
Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G: Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 1997;94:6965–6970.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.